Omeros Announces Positive OMS721 Data in Model of Thrombotic ... PipelineReview.com (press release) SEATTLE, WA, USA I April 2, 2013 I Omeros Corporation (OMER) today announced positive data using OMS721, the lead human monoclonal antibody in Omeros' mannan-binding lectin-associated serine protease-2 (MASP-2) program, in a well-established ... |
